Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reported $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Janssen representative Michelle Bauer said Monday that the settlement isn’t an admission of liability.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Ex-CEO, Ex-CFO of Bankrupt AI Company Charged With Fraud 
How Niche Insurance Shielded Bad Bunny From Bad Weather 
Oil Trader CFOs Say Hormuz Closure Driving Wave of Disputes 
Viewpoint: Japan’s $550B Bet on America—What it Means for the US Insurance Market 
